.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Teva
Federal Trade Commission
Daiichi Sankyo
Accenture
Cerilliant
Colorcon
Baxter
Medtronic
Merck
Johnson and Johnson

Generated: June 24, 2017

DrugPatentWatch Database Preview

Claims for Patent: 4,687,777

« Back to Dashboard

Claims for Patent: 4,687,777

Title: Thiazolidinedione derivatives, useful as antidiabetic agents
Abstract:Thiazolidinedione derivatives of the formula: ##STR1## and pharmacologically acceptable salts thereof are novel compounds, which exhibit in mammals blood sugar- and lipid-lowering activity, and are of value as a therapeutic agent for treatment of diabetes and hyperlipemia.
Inventor(s): Meguro; Kanji (Nishinomiya, JP), Fujita; Takeshi (Takarazuka, JP)
Assignee: Takeda Chemical Industries, Ltd. (Osaka, JP)
Application Number:06/820,390
Patent Claims: 1. A compound of the formula: ##STR15## or a pharmacologically acceptable salt thereof.

2. A compound as claimed in claim 1, wherein the compound is 5-{4-[2-(5-ethyl-2-pyridyl)ethoxy]benzyl}-2,4-thiazolidinedione.

3. A compound as claimed in claim 1, wherein the compound is sodium salt of 5-{4-[2-(5-ethyl-2-pyridyl)ethoxy]benzylbenzyl}-2,4-thiazolidinedione.

4. A compound as claimed in claim 1, wherein the compound is 5-{4-[2-(6-ethyl-2-pyridyl)ethoxy]benzyl}-2,4-thiazolidinedione.

5. An antidiabetic composition which consists essentially of a compound of the formula: ##STR16## or a pharmacologically acceptable salt thereof, in association with a pharmacologically acceptable carrier, excipient or diluent.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
Julphar
Farmers Insurance
Accenture
Cerilliant
Medtronic
Harvard Business School
McKesson
Cipla
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot